1. Home
  2. 🏥 Medical
  3. myVUMERITY
myVUMERITY

myVUMERITY

by Biogen Inc.

20 ratings
9 reviews
🏥 Medical
Free

Details

Released
December 18, 2019
Updated
May 12, 2026

Features

Developer

Biogen Inc.
✨Promote your app ✨
myVUMERITY screenshot #1 for iPhone
myVUMERITY screenshot #2 for iPhone
myVUMERITY screenshot #3 for iPhone
myVUMERITY screenshot #4 for iPhone
⭐9
Reviews↘︎
📝2+ tags
Tags↘︎
🔄5+ apps
Alternatives↘︎
❓8 answered
FAQ↘︎
📦~ in 2 months
Updates frequency↘︎
🖼️Get Icon
Icons↘︎

About

This app helps users manage their VUMERITY treatment by tracking daily doses, setting reminders, and logging lab tests. It facilitates better preparation for discussions with healthcare providers.

✓Track daily doses
✓Personalized treatment reminders
✓Keep track of lab tests
✓Access activity log
✓Prepare for healthcare provider conversations
Show original description

What's New in myVUMERITY

2.1.1

May 12, 2026

Bug fixes and updates

User reviews

Most RecentHighest RatedLowest Rated

App not working!

Like a previous patient the app has stopped working after recent apple’s update to 26.2 for I phone. I don’t see any recent updates to correct app not opening. Appreciate any help or fixes to continue using app. Important!
Ooclapi

Update bricked app

I used this app daily but with new update the only bug it fixed was making it nonfunctional and won’t even open without crashing
SSingNmyHrtOut

Recent update

Uninstalling/deleting the app and then reinstalling and logging back in fixed the issues and updated to the new interface.
RRainbow7*

App user

Since the latest iOS upgrade, vumerity app will not open. Recycled phone, removed app & reinstalled.
Iiggnacious

Latest update

The app updated 2 days ago and now it doesn’t open. If it does, stays on main screen and nothing else. Haven’t logged meds since Monday. This sucks.
SshortiP
See 4 more reviews

Developer apps

CogEval
CogEval

by Biogen Inc.

💪 Health & Fitness

(2)

Free
Cleo : mieux vivre avec la SEP
Cleo : mieux vivre avec la SEP

Suivi sclérose en plaques

🏥 Medical

(66)

Aby
Aby

App to support your MS journey

🏥 Medical

(52)

Free
Cleo クレオ
Cleo クレオ

by Biogen Inc.

🏥 Medical

(26)

Neurodiem
Neurodiem

by Biogen Inc.

🏥 Medical

(1)

Free
See developer apps

FAQ

What is myVUMERITY used for?

myVUMERITY is designed to help you track your VUMERITY (diroximel fumarate) treatment. It allows you to monitor daily doses, set reminders, and log lab tests to better prepare for conversations with your healthcare provider.

Is myVUMERITY free to download and use?

Yes, myVUMERITY is available for free. The app does not have any in-app purchases or advertisements, making it a completely free tool for managing your treatment.

What devices does myVUMERITY support?

myVUMERITY is currently supported on iPhone and iPod devices. It is designed to be accessible on these Apple mobile platforms.

How often is myVUMERITY updated?

The latest version of myVUMERITY is 2.1, which was last updated on April 14, 2026. While this indicates a recent update, the frequency of future updates will depend on Biogen Inc.'s development schedule.

What is the age rating for myVUMERITY?

myVUMERITY has an age rating of 17+. This suggests that the content or functionality of the app is deemed appropriate for users aged 17 and above.

Can myVUMERITY replace discussions with a healthcare provider?

No, myVUMERITY is not intended to replace discussions with your healthcare provider. It serves as a tool to help you organize information and prepare for those important medical consultations.

Where can I find important safety information for VUMERITY?

Important Safety Information for VUMERITY can be found in the full Prescribing Information at https://www.VUMERITY.com/pdfs/full-prescribing-info.pdf and Patient Information at https://www.VUMERITY.com/pdfs/patient-information.pdf.

What is the user feedback on myVUMERITY based on ratings?

myVUMERITY has a rating of 3.1 stars from 17 ratings. This indicates a mixed to slightly positive user reception, suggesting areas for potential improvement or features that are well-received.